During the past decade, Sei Womens Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sei Womens Clinic" are "Leiomyoma" (1 trials) and "Uterine Fibroids and Heavy Menstrual Bleeding" (1 trials). Many other conditions were trialed in "Sei Womens Clinic" in a lesser frequency.

Most popular intervention types in "Sei Womens Clinic" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Vilaprisan (BAY1002670)" (2 trials) and "Standard of care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sei Womens Clinic" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Sei Womens Clinic". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sei Womens Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sei Womens Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".